Skip to content
PICO Portalanswers from OpenAlex

Targeting brain lesions of non-small cell lung cancer by enhancing CCL2-mediated CAR-T cell migration

PaperCitations, authors & open-access status

Targeting brain lesions of non-small cell lung cancer by enhancing CCL2-mediated CAR-T cell migration is a paper indexed in PICO Portal from OpenAlex.

How many citations does Targeting brain lesions of non-small cell lung cancer by enhancing CCL2-mediated CAR-T cell migration have?

PICO Portalcitation count

Targeting brain lesions of non-small cell lung cancer by enhancing CCL2-mediated CAR-T cell migration has 103 citations in the OpenAlex counts PICO Portal stores.

When was Targeting brain lesions of non-small cell lung cancer by enhancing CCL2-mediated CAR-T cell migration published?

PICO Portalyear

Targeting brain lesions of non-small cell lung cancer by enhancing CCL2-mediated CAR-T cell migration has 2022 year in the PICO Portal index.

What is the open-access status of Targeting brain lesions of non-small cell lung cancer by enhancing CCL2-mediated CAR-T cell migration?

PICO Portaloa status

Targeting brain lesions of non-small cell lung cancer by enhancing CCL2-mediated CAR-T cell migration has gold oa status in the PICO Portal index.

What is the DOI of Targeting brain lesions of non-small cell lung cancer by enhancing CCL2-mediated CAR-T cell migration?

PICO Portaldoi

The DOI for Targeting brain lesions of non-small cell lung cancer by enhancing CCL2-mediated CAR-T cell migration is on the source record.

What is the PMID of Targeting brain lesions of non-small cell lung cancer by enhancing CCL2-mediated CAR-T cell migration?

PICO Portalpmid

The PMID for Targeting brain lesions of non-small cell lung cancer by enhancing CCL2-mediated CAR-T cell migration is on the source record.

What is the OpenAlex record for Targeting brain lesions of non-small cell lung cancer by enhancing CCL2-mediated CAR-T cell migration?

PICO Portalopenalex

The OpenAlex for Targeting brain lesions of non-small cell lung cancer by enhancing CCL2-mediated CAR-T cell migration is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial